Who Can Use Ozempic Injection? Understanding Eligibility and Guidelines

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection has become a widely prescribed treatment for weight management in adults with particular metabolic conditions. The medication works by slowing digestion and increasing feelings of fullness, helping reduce calorie intake by an average of 500-750 calories per day in clinical trials. Understanding who qualifies for this therapy is the first step toward personalized weight loss treatment.

BMI and Weight Loss Criteria for Semaglutide Eligibility

Medical guidelines suggest semaglutide injection is appropriate for adults with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who also have weight-related health conditions. Weight-related conditions include high blood pressure, type 2 diabetes, heart disease, or sleep apnea. PlexusDx reviews your specific BMI calculation and any comorbidities during your initial consultation to confirm suitability.

The threshold of BMI 27 reflects clinical evidence showing that even modest weight loss at lower BMI levels produces measurable improvements in blood sugar control and cardiovascular risk markers. Some patients below a BMI of 27 may still qualify if they demonstrate metabolic risk factors or insulin resistance on screening tests. Your health history matters more than a single number on a scale.

Medical History Factors That Determine Semaglutide Candidacy

A complete medical history helps PlexusDx identify whether semaglutide injection is safe and effective for your situation. The assessment includes questions about thyroid cancer, pancreatitis, gallbladder disease, diabetes type and duration, current medications, and any family history of medullary thyroid carcinoma. Certain conditions require additional monitoring or may rule out semaglutide use entirely, which is why an honest conversation about your past health events is essential.

Patients with a personal or family history of medullary thyroid cancer cannot use semaglutide, as animal studies showed thyroid tumors in rodents exposed to the medication. Similarly, those with a history of acute pancreatitis should discuss alternative options with their provider. PlexusDx providers perform a thorough risk-benefit analysis before approval, ensuring your safety comes first.

Age and Medication Interaction Screening

Semaglutide injection is approved for adults aged 18 and older. Age alone does not determine eligibility—instead, PlexusDx evaluates kidney and liver function, medication interactions, and overall metabolic health regardless of how old you are. Older adults often benefit from dose adjustments and closer monitoring, but age is not a barrier to access.

Drug interactions can alter how semaglutide works or increase side effect risk. Medications that slow stomach emptying, certain diabetes drugs, and some blood pressure medications require careful coordination with semaglutide therapy. PlexusDx reviews your complete medication list before starting treatment to prevent harmful interactions and ensure optimal outcomes.

How PlexusDx Assesses Your Semaglutide Injection Eligibility

PlexusDx uses a multi-step eligibility process: an online health questionnaire, a consultation with a licensed provider, and optional genetic testing through the Precision Peptide Genetic Test. This test analyzes key genetic variants in GLP-1 receptor pathways, FTO, and MC4R genes to predict how your body may respond to semaglutide before you start treatment. Understanding your genetic predispositions helps match you with the most effective therapy from day one.

Once approved, PlexusDx delivers compounded semaglutide injection from licensed 503A compounding pharmacies, starting at just $149 per month with no membership fees or insurance required. The pricing remains flat regardless of your dose level—your dose may need to go up, but your price won't. HSA and FSA accounts are accepted, making treatment more affordable for eligible patients.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What BMI do I need to qualify for semaglutide injection at PlexusDx?

Most patients qualify with a BMI of 30 or higher, or a BMI of 27 or higher plus at least one weight-related condition like high blood pressure or type 2 diabetes. PlexusDx providers review your individual health profile to confirm eligibility during your consultation.

Can I use semaglutide if I have type 2 diabetes?

Yes, semaglutide injection is often prescribed to people with type 2 diabetes as it improves blood sugar control while promoting weight loss. Notify PlexusDx of your diabetes type, current medications, and blood sugar levels so your provider can monitor you appropriately and adjust your diabetes medications if needed.

How much does semaglutide injection cost at PlexusDx, and is there a membership?

PlexusDx compounded semaglutide injection starts at $149 per month with no membership fees, insurance requirement, or flat per-compound pricing increases. HSA and FSA funds are accepted, reducing your out-of-pocket cost further.

Are there any conditions that would prevent me from using semaglutide?

Yes, a personal or family history of medullary thyroid cancer is a contraindication, as is a history of acute pancreatitis in some cases. Thyroid nodules, severe kidney disease, and certain stomach disorders may also affect eligibility. PlexusDx providers will review your complete medical history to ensure safety.

What is the Precision Peptide Genetic Test, and how does it help determine my eligibility?

PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes 14 metabolic pathways and 49 peptides, including GLP-1 receptor variants and FTO gene mutations, to predict your response to semaglutide before starting. This personalized insight helps confirm that semaglutide is the right choice and optimizes your treatment from the beginning.

Related Reading

• Injection Ozempic
• Injection Sites For Ozempic
• Ozempic Injection Sites
• Ozempic Injection

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.